{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T19:05:01Z","timestamp":1762455901772,"version":"build-2065373602"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,6,24]],"date-time":"2019-06-24T00:00:00Z","timestamp":1561334400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004097","name":"Fondation ARC pour la Recherche sur le Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004097","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000900","name":"California Institute for Regenerative Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000900","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["EBioMedicine"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.ebiom.2019.06.047","type":"journal-article","created":{"date-parts":[[2019,7,4]],"date-time":"2019-07-04T17:28:06Z","timestamp":1562261286000},"page":"39-57","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Combinatorial targeting of cancer bone metastasis using mRNA engineered stem cells"],"prefix":"10.1016","volume":"45","author":[{"given":"Aude I.","family":"Segaliny","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason L.","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry P.","family":"Farhoodi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Toledano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih Chun","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatrice","family":"Tierra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leanne","family":"Hildebrand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaedu","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongxu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lizhi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gultekin","family":"Gulsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min-Ying","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert L.","family":"Sah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.ebiom.2019.06.047_bb0005","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/nrc867","article-title":"Metastasis to bone: causes, consequences and therapeutic opportunities","volume":"2","author":"Mundy","year":"2002","journal-title":"Nat Rev Cancer"},{"issue":"8","key":"10.1016\/j.ebiom.2019.06.047_bb0010","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1002\/(SICI)1097-0142(19971015)80:8+<1588::AID-CNCR9>3.0.CO;2-G","article-title":"Skeletal complications of malignancy","volume":"80","author":"Coleman","year":"1997","journal-title":"Cancer."},{"issue":"10","key":"10.1016\/j.ebiom.2019.06.047_bb0015","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17101674","article-title":"Cancer cell colonisation in the bone microenvironment","volume":"17","author":"Kan","year":"2016","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.ebiom.2019.06.047_bb0020","first-page":"7","article-title":"Cancer statistics, 2017","volume":"67","author":"Siegel","year":"2017","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"10.1016\/j.ebiom.2019.06.047_bb0025","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1634\/theoncologist.5-6-463","article-title":"Management of bone metastases","volume":"5","author":"Coleman","year":"2000","journal-title":"Oncologist."},{"issue":"14","key":"10.1016\/j.ebiom.2019.06.047_bb0030","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1093\/jnci\/djs263","article-title":"Effects of bone-targeted agents on cancer progression and mortality","volume":"104","author":"Coleman","year":"2012","journal-title":"J Natl Cancer Inst"},{"issue":"Suppl. 1","key":"10.1016\/j.ebiom.2019.06.047_bb0035","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.3747\/co.v15i0.205","article-title":"A primer of bone metastases management in breast cancer patients","volume":"15","author":"Petrut","year":"2008","journal-title":"Curr Oncol"},{"issue":"6","key":"10.1016\/j.ebiom.2019.06.047_bb0040","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nrc3055","article-title":"Cancer to bone: a fatal attraction","volume":"11","author":"Weilbaecher","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ebiom.2019.06.047_bb0045","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jconrel.2014.04.057","article-title":"Bone marrow endothelium-targeted therapeutics for metastatic breast cancer","volume":"187","author":"Mai","year":"2014","journal-title":"J Control Release"},{"issue":"3","key":"10.1016\/j.ebiom.2019.06.047_bb0050","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2174\/1389450116666150427154706","article-title":"Nanoparticles-based treatment for bone metastasis","volume":"17","author":"Saracino","year":"2016","journal-title":"Curr Drug Targets"},{"issue":"1","key":"10.1016\/j.ebiom.2019.06.047_bb0055","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/nrc3180","article-title":"Treating metastatic cancer with nanotechnology","volume":"12","author":"Schroeder","year":"2011","journal-title":"Nat Rev Cancer"},{"issue":"28","key":"10.1016\/j.ebiom.2019.06.047_bb0060","doi-asserted-by":"crossref","first-page":"10287","DOI":"10.1073\/pnas.1401337111","article-title":"Engineered nanomedicine for myeloma and bone microenvironment targeting","volume":"111","author":"Swami","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"19","key":"10.1016\/j.ebiom.2019.06.047_bb0065","doi-asserted-by":"crossref","first-page":"6264","DOI":"10.1039\/C7NR00962C","article-title":"Redox and pH dual sensitive bone targeting nanoparticles to treat breast cancer bone metastases and inhibit bone resorption","volume":"9","author":"Zhao","year":"2017","journal-title":"Nanoscale."},{"issue":"5","key":"10.1016\/j.ebiom.2019.06.047_bb0070","doi-asserted-by":"crossref","DOI":"10.1038\/natrevmats.2016.14","article-title":"Analysis of nanoparticle delivery to tumours","volume":"1","author":"Wilhelm","year":"2016","journal-title":"Nat Rev Mater"},{"issue":"5","key":"10.1016\/j.ebiom.2019.06.047_bb0075","doi-asserted-by":"crossref","first-page":"651","DOI":"10.18632\/oncotarget.1040","article-title":"To grab the stroma by the horns: from biology to cancer therapy with mesenchymal stem cells","volume":"4","author":"Droujinine","year":"2013","journal-title":"Oncotarget."},{"issue":"8","key":"10.1016\/j.ebiom.2019.06.047_bb0080","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.addr.2011.06.010","article-title":"Mesenchymal stem cells engineered for cancer therapy","volume":"64","author":"Shah","year":"2012","journal-title":"Adv Drug Deliv Rev"},{"issue":"30","key":"10.1016\/j.ebiom.2019.06.047_bb0085","doi-asserted-by":"crossref","first-page":"E6157","DOI":"10.1073\/pnas.1700363114","article-title":"Stem cell-released oncolytic herpes simplex virus has therapeutic efficacy in brain metastatic melanomas","volume":"114","author":"Du","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"issue":"9","key":"10.1016\/j.ebiom.2019.06.047_bb0090","doi-asserted-by":"crossref","first-page":"3718","DOI":"10.1158\/0008-5472.CAN-09-1865","article-title":"Adipose-derived mesenchymal stem cells as stable source of tumor necrosis factor-related apoptosis-inducing ligand delivery for Cancer therapy","volume":"70","author":"Grisendi","year":"2010","journal-title":"Cancer Res"},{"issue":"400","key":"10.1016\/j.ebiom.2019.06.047_bb0095","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aan2966","article-title":"Mechanoresponsive stem cells to target cancer metastases through biophysical cues","volume":"9","author":"Liu","year":"2017","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.ebiom.2019.06.047_bb0100","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-015-0149-2","article-title":"Combined enzyme\/prodrug treatment by genetically engineered AT-MSC exerts synergy and inhibits growth of MDA-MB-231 induced lung metastases","volume":"34","author":"Matuskova","year":"2015","journal-title":"J Exp Clin Cancer Res"},{"issue":"13","key":"10.1016\/j.ebiom.2019.06.047_bb0105","first-page":"3603","article-title":"Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors","volume":"62","author":"Studeny","year":"2002","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.ebiom.2019.06.047_bb0110","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.scr.2013.09.010","article-title":"Selective antitumor effect of neural stem cells expressing cytosine deaminase and interferon-beta against ductal breast cancer cells in cellular and xenograft models","volume":"12","author":"Yi","year":"2014","journal-title":"Stem Cell Res"},{"key":"10.1016\/j.ebiom.2019.06.047_bb0115","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1186\/s12885-015-1241-x","article-title":"Treatment of advanced gastrointestinal tumors with genetically modified autologous mesenchymal stromal cells (TREAT-ME1): study protocol of a phase I\/II clinical trial","volume":"15","author":"Niess","year":"2015","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.ebiom.2019.06.047_bb0120","first-page":"165","article-title":"Constitutive expression of E-selectin and vascular cell adhesion molecule-1 on endothelial cells of hematopoietic tissues","volume":"148","author":"Schweitzer","year":"1996","journal-title":"Am J Pathol"},{"issue":"7044","key":"10.1016\/j.ebiom.2019.06.047_bb0125","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1038\/nature03703","article-title":"In vivo imaging of specialized bone marrow endothelial microdomains for tumour engraftment","volume":"435","author":"Sipkins","year":"2005","journal-title":"Nature."},{"issue":"10","key":"10.1016\/j.ebiom.2019.06.047_bb0130","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1182\/blood-2004-02-0650","article-title":"Surface fucosylation of human cord blood cells augments binding to P-selectin and E-selectin and enhances engraftment in bone marrow","volume":"104","author":"Xia","year":"2004","journal-title":"Blood."},{"key":"10.1016\/j.ebiom.2019.06.047_bb0135","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jconrel.2015.01.003","article-title":"Genetically engineered theranostic mesenchymal stem cells for the evaluation of the anticancer efficacy of enzyme\/prodrug systems","volume":"200","author":"Nouri","year":"2015","journal-title":"J Control Release"},{"issue":"3 Suppl","key":"10.1016\/j.ebiom.2019.06.047_bb0140","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1002\/cncr.11138","article-title":"A phase I study of AMGN-0007, a recombinant osteoprotegerin construct, in patients with multiple myeloma or breast carcinoma related bone metastases","volume":"97","author":"Body","year":"2003","journal-title":"Cancer."},{"issue":"5","key":"10.1016\/j.ebiom.2019.06.047_bb0145","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1158\/1541-7786.MCR-14-0492","article-title":"Variants of osteoprotegerin lacking TRAIL binding for therapeutic bone remodeling in osteolytic malignancies","volume":"13","author":"Higgs","year":"2015","journal-title":"Mol Cancer Res"},{"issue":"3\u20135","key":"10.1016\/j.ebiom.2019.06.047_bb0150","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/jgm.2826","article-title":"Targeted inhibition of osteosarcoma tumor growth by bone marrow-derived mesenchymal stem cells expressing cytosine deaminase\/5-fluorocytosine in tumor-bearing mice","volume":"17","author":"NguyenThai","year":"2015","journal-title":"J Gene Med"},{"key":"10.1016\/j.ebiom.2019.06.047_bb0155","doi-asserted-by":"crossref","first-page":"969","DOI":"10.2147\/DDDT.S77116","article-title":"Human mesenchymal stem cells as delivery of osteoprotegerin gene: homing and therapeutic effect for osteosarcoma","volume":"9","author":"Qiao","year":"2015","journal-title":"Drug Des Dev Ther"},{"issue":"11","key":"10.1016\/j.ebiom.2019.06.047_bb0160","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1038\/mt.2008.200","article-title":"Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability","volume":"16","author":"Kariko","year":"2008","journal-title":"Mol Ther"},{"issue":"6","key":"10.1016\/j.ebiom.2019.06.047_bb0165","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1172\/JCI92030","article-title":"mRNA-mediated glycoengineering ameliorates deficient homing of human stem cell-derived hematopoietic progenitors","volume":"127","author":"Lee","year":"2017","journal-title":"J Clin Invest"},{"issue":"14","key":"10.1016\/j.ebiom.2019.06.047_bb0170","doi-asserted-by":"crossref","first-page":"E23","DOI":"10.1182\/blood-2013-04-495119","article-title":"mRNA-engineered mesenchymal stem cells for targeted delivery of interleukin-10 to sites of inflammation","volume":"122","author":"Levy","year":"2013","journal-title":"Blood."},{"issue":"6","key":"10.1016\/j.ebiom.2019.06.047_bb0175","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1634\/stemcells.20-6-530","article-title":"Expansion of human adult stem cells from bone marrow stroma: conditions that maximize the yields of early progenitors and evaluate their quality","volume":"20","author":"Sekiya","year":"2002","journal-title":"Stem Cells"},{"issue":"4","key":"10.1016\/j.ebiom.2019.06.047_bb0180","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement","volume":"8","author":"Dominici","year":"2006","journal-title":"Cytotherapy."},{"key":"10.1016\/j.ebiom.2019.06.047_bb0185","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-05366-3","article-title":"A reliable murine model of bone metastasis by injecting cancer cells through caudal arteries","volume":"9","author":"Kuchimaru","year":"2018","journal-title":"Nat Commun"},{"issue":"7","key":"10.1016\/j.ebiom.2019.06.047_bb0190","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1200\/JCO.1989.7.7.890","article-title":"Fluorouracil and high-dose leucovorin in previously treated patients with metastatic breast-Cancer","volume":"7","author":"Swain","year":"1989","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.ebiom.2019.06.047_bb0195","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1023\/A:1020992411420","article-title":"Quantification of human Alu sequences by real-time PCR--an improved method to measure therapeutic efficacy of anti-metastatic drugs in human xenotransplants","volume":"19","author":"Schneider","year":"2002","journal-title":"Clin Exp Metastasis"},{"key":"10.1016\/j.ebiom.2019.06.047_bb0200","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.2337\/db15-1404","article-title":"Erratum. Amelioration of Diabetes by Protein S","volume":"65","author":"Yasuma","year":"2016","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.ebiom.2019.06.047_bb0205","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1080\/14653240310000038","article-title":"Quantifying levels of transplanted murine and human mesenchymal stem cells in vivo by real-time PCR","volume":"5","author":"McBride","year":"2003","journal-title":"Cytotherapy."},{"key":"10.1016\/j.ebiom.2019.06.047_bb0210","article-title":"Highly sensitive and specific Alu-based quantification of human cells among rodent cells","volume":"7","author":"Funakoshi","year":"2017","journal-title":"Sci Rep-UK"},{"issue":"9","key":"10.1016\/j.ebiom.2019.06.047_bb0215","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/nri2156","article-title":"Getting to the site of inflammation: the leukocyte adhesion cascade updated","volume":"7","author":"Ley","year":"2007","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"10.1016\/j.ebiom.2019.06.047_bb0220","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.cytogfr.2013.06.001","article-title":"Osteoprotegerin: multiple partners for multiple functions","volume":"24","author":"Baud'huin","year":"2013","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.ebiom.2019.06.047_bb0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2017.08.016","article-title":"Targeted antitumor therapy mediated by prodrug-activating mesenchymal stromal cells","volume":"408","author":"Kucerova","year":"2017","journal-title":"Cancer Lett"},{"issue":"2","key":"10.1016\/j.ebiom.2019.06.047_bb0230","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1215\/15228517-2005-012","article-title":"Targeting of melanoma brain metastases using engineered neural stem\/progenitor cells","volume":"8","author":"Aboody","year":"2006","journal-title":"Neuro-Oncology."},{"issue":"1","key":"10.1016\/j.ebiom.2019.06.047_bb0235","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/bjc.1994.259","article-title":"Continuous 5-fluorouracil in the treatment of breast cancer","volume":"70","author":"Cameron","year":"1994","journal-title":"Br J Cancer"},{"issue":"11","key":"10.1016\/j.ebiom.2019.06.047_bb0240","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1038\/nm.2969","article-title":"Vascular niche E-selectin regulates hematopoietic stem cell dormancy, self renewal and chemoresistance","volume":"18","author":"Winkler","year":"2012","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.ebiom.2019.06.047_bb0245","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.canlet.2012.02.019","article-title":"Selectin-deficiency reduces the number of spontaneous metastases in a xenograft model of human breast cancer","volume":"321","author":"Stubke","year":"2012","journal-title":"Cancer Lett"},{"key":"10.1016\/j.ebiom.2019.06.047_bb0250","doi-asserted-by":"crossref","DOI":"10.1038\/bonekey.2016.31","article-title":"Murine models of breast cancer bone metastasis","volume":"5","author":"Wright","year":"2016","journal-title":"Bonekey Rep"},{"issue":"2","key":"10.1016\/j.ebiom.2019.06.047_bb0255","first-page":"148","article-title":"Intra-tibial injection of human prostate cancer cell line CWR22 elicits osteoblastic response in immunodeficient rats","volume":"3","author":"Andersen","year":"2003","journal-title":"J Musculoskelet Neuronal Interact"},{"issue":"3","key":"10.1016\/j.ebiom.2019.06.047_bb0260","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.stem.2009.02.001","article-title":"Mesenchymal stem cell homing: the devil is in the details","volume":"4","author":"Karp","year":"2009","journal-title":"Cell Stem Cell"},{"issue":"7","key":"10.1016\/j.ebiom.2019.06.047_bb0265","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1002\/stem.81","article-title":"Trafficking mesenchymal stem cell engraftment and differentiation in tumor-bearing mice by bioluminescence imaging","volume":"27","author":"Wang","year":"2009","journal-title":"Stem Cells"},{"issue":"4","key":"10.1016\/j.ebiom.2019.06.047_bb0270","doi-asserted-by":"crossref","first-page":"532","DOI":"10.4161\/cbt.7.4.5481","article-title":"A new rat model of human breast cancer for evaluating efficacy of new anti-cancer agents in vivo","volume":"7","author":"Direcks","year":"2008","journal-title":"Cancer Biol Ther"},{"issue":"1","key":"10.1016\/j.ebiom.2019.06.047_bb0275","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13287-016-0311-6","article-title":"Delineating the effects of 5-fluorouracil and follicle-stimulating hormone on mouse bone marrow stem\/progenitor cells","volume":"7","author":"Shaikh","year":"2016","journal-title":"Stem Cell Res Ther"},{"issue":"6","key":"10.1016\/j.ebiom.2019.06.047_bb0280","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1002\/ijc.11330","article-title":"Effects of oral UFT combined with or without zoledronic acid on bone metastasis in the 4T1\/luc mouse breast cancer","volume":"106","author":"Hiraga","year":"2003","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ebiom.2019.06.047_bb0285","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/978-3-642-21892-7_7","article-title":"Combinations of bisphosphonates and classical anticancer drugs: a preclinical perspective","volume":"192","author":"Michailidou","year":"2012","journal-title":"Recent Results Cancer Res"},{"issue":"4","key":"10.1016\/j.ebiom.2019.06.047_bb0290","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1002\/ijc.29439","article-title":"OPG-fc inhibits ovariectomy-induced growth of disseminated breast cancer cells in bone","volume":"137","author":"Ottewell","year":"2015","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1016\/j.ebiom.2019.06.047_bb0295","doi-asserted-by":"crossref","first-page":"1","DOI":"10.55782\/ane-2013-1918","article-title":"Genetic engineering of stem cells for enhanced therapy","volume":"73","author":"Nowakowski","year":"2013","journal-title":"Acta Neurobiol Exp"},{"issue":"5","key":"10.1016\/j.ebiom.2019.06.047_bb0300","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nrg1066","article-title":"Progress and problems with the use of viral vectors for gene therapy","volume":"4","author":"Thomas","year":"2003","journal-title":"Nat Rev Genet"},{"issue":"2","key":"10.1016\/j.ebiom.2019.06.047_bb0305","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0301-472X(00)00635-4","article-title":"Mesenchymal stem cells are capable of homing to the bone marrow of non-human primates following systemic infusion","volume":"29","author":"Devine","year":"2001","journal-title":"Exp Hematol"},{"issue":"10","key":"10.1016\/j.ebiom.2019.06.047_bb0310","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1002\/stem.187","article-title":"Direct evidence of mesenchymal stem cell tropism for tumor and wounding microenvironments using in vivo bioluminescent imaging","volume":"27","author":"Kidd","year":"2009","journal-title":"Stem Cells"},{"issue":"8","key":"10.1016\/j.ebiom.2019.06.047_bb0315","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1158\/0008-5472.CAN-16-1084","article-title":"Role of megakaryocytes in breast Cancer metastasis to bone","volume":"77","author":"Jackson","year":"2017","journal-title":"Cancer Res"},{"issue":"345","key":"10.1016\/j.ebiom.2019.06.047_bb0320","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaf7374","article-title":"P-selectin is a nanotherapeutic delivery target in the tumor microenvironment","volume":"8","author":"Shamay","year":"2016","journal-title":"Sci Transl Med"},{"issue":"4","key":"10.1016\/j.ebiom.2019.06.047_bb0325","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/nrendo.2010.227","article-title":"Bone metastasis: mechanisms and therapeutic opportunities","volume":"7","author":"Suva","year":"2011","journal-title":"Nat Rev Endocrinol"},{"issue":"9","key":"10.1016\/j.ebiom.2019.06.047_bb0330","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1096\/fj.10-178384","article-title":"Mimicking the inflammatory cell adhesion cascade by nucleic acid aptamer programmed cell-cell interactions","volume":"25","author":"Zhao","year":"2011","journal-title":"FASEB J"},{"issue":"3","key":"10.1016\/j.ebiom.2019.06.047_bb0335","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/BF03033743","article-title":"Alterations of microvascular density in bone metastases of adenocarcinomas","volume":"10","author":"Lorincz","year":"2004","journal-title":"Pathol Oncol Res"},{"issue":"24","key":"10.1016\/j.ebiom.2019.06.047_bb0340","doi-asserted-by":"crossref","first-page":"11687","DOI":"10.1158\/0008-5472.CAN-07-1406","article-title":"Tumor irradiation increases the recruitment of circulating mesenchymal stem cells into the tumor microenvironment","volume":"67","author":"Klopp","year":"2007","journal-title":"Cancer Res"},{"issue":"2","key":"10.1016\/j.ebiom.2019.06.047_bb0345","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nm1703","article-title":"Ex vivo glycan engineering of CD44 programs human multipotent mesenchymal stromal cell trafficking to bone","volume":"14","author":"Sackstein","year":"2008","journal-title":"Nat Med"},{"issue":"6","key":"10.1016\/j.ebiom.2019.06.047_bb0350","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.exphem.2011.03.004","article-title":"Genetically modified adipose tissue-derived mesenchymal stem cells overexpressing CXCR4 display increased motility, invasiveness, and homing to bone marrow of NOD\/SCID mice","volume":"39","author":"Bobis-Wozowicz","year":"2011","journal-title":"Exp Hematol"},{"issue":"9","key":"10.1016\/j.ebiom.2019.06.047_bb0355","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1182\/blood-2004-02-0526","article-title":"A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrow","volume":"104","author":"Wynn","year":"2004","journal-title":"Blood."},{"issue":"9624","key":"10.1016\/j.ebiom.2019.06.047_bb0360","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/S0140-6736(08)60690-X","article-title":"Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study","volume":"371","author":"LeBlanc","year":"2008","journal-title":"Lancet."},{"issue":"4","key":"10.1016\/j.ebiom.2019.06.047_bb0365","doi-asserted-by":"crossref","first-page":"661","DOI":"10.3727\/096368915X687796","article-title":"Continuous improvement after multiple mesenchymal stem cell transplantations in a patient with complete spinal cord injury","volume":"24","author":"Jarocha","year":"2015","journal-title":"Cell Transplant"},{"issue":"10","key":"10.1016\/j.ebiom.2019.06.047_bb0370","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1038\/gt.2014.66","article-title":"Long-term efficiency of mesenchymal stromal cell-mediated CD-MSC\/5FC therapy in human melanoma xenograft model","volume":"21","author":"Kucerova","year":"2014","journal-title":"Gene Ther"},{"key":"10.1016\/j.ebiom.2019.06.047_bb0375","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bej.2015.12.017","article-title":"Scale-up and manufacturing of cell-based therapies IV","volume":"108","author":"Special issue on Cell Therapy Manufacturing and Scale-Up Introduction: TA Brieva, Celgene","year":"2016","journal-title":"Biochem Eng J"},{"issue":"10","key":"10.1016\/j.ebiom.2019.06.047_bb0380","first-page":"A11","article-title":"Chemically modified guide RNAs enhance CRISPR\/Cas genome editing in human primary cells","volume":"26","author":"Bak","year":"2015","journal-title":"Hum Gene Ther"},{"issue":"6","key":"10.1016\/j.ebiom.2019.06.047_bb0385","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nbt.3843","article-title":"Targeting genomic rearrangements in tumor cells through Cas9-mediated insertion of a suicide gene","volume":"35","author":"Chen","year":"2017","journal-title":"Nat Biotechnol"}],"container-title":["EBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396419304281?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396419304281?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T18:55:28Z","timestamp":1762455328000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396419304281"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":77,"alternative-id":["S2352396419304281"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2019.06.047","relation":{},"ISSN":["2352-3964"],"issn-type":[{"type":"print","value":"2352-3964"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combinatorial targeting of cancer bone metastasis using mRNA engineered stem cells","name":"articletitle","label":"Article Title"},{"value":"EBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2019.06.047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}